CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Rosemary Harrison Joins TCR Therapeutics as Chief Business and Strategy Officer

Rosemary Harrison Joins TCR...

Catalyst Biosciences Announces Major Leadership Changes

Catalyst Biosciences Announces Major...

Merakris Therapeutics Partners with Miracles In Sight Eye Bank

Merakris Therapeutics Partners with...

BetterLife- Carleton University Research Team Secures Funding form Mitacs

BetterLife- Carleton University...

ClearPoint Neuro Appoints Lynnette C. Fallon to Board of Directors

ClearPoint Neuro Appoints Lynnette C....

Marc Drimer, CPA, Joins the Board of Directors of Curative Biotechnology

Marc Drimer, CPA, Joins the Board of...

James Pekarsky Joins Gelteq as Chief Financial Officer

James Pekarsky Joins Gelteq as Chief...

BioStem Technologies Announces the Approval of Q Code for VENDAJE from CMS

BioStem Technologies Announces the...

Rosemary Harrison Joins TCR Therapeutics as Chief Business and Strategy Officer

Rosemary Harrison Joins TCR...

Catalyst Biosciences Announces Major Leadership Changes

Catalyst Biosciences Announces Major...

Merakris Therapeutics Partners with Miracles In Sight Eye Bank

Merakris Therapeutics Partners with...

BetterLife- Carleton University Research Team Secures Funding form Mitacs

BetterLife- Carleton University...

ClearPoint Neuro Appoints Lynnette C. Fallon to Board of Directors

ClearPoint Neuro Appoints Lynnette C....

Marc Drimer, CPA, Joins the Board of Directors of Curative Biotechnology

Marc Drimer, CPA, Joins the Board of...

James Pekarsky Joins Gelteq as Chief Financial Officer

James Pekarsky Joins Gelteq as Chief...

BioStem Technologies Announces the Approval of Q Code for VENDAJE from CMS

BioStem Technologies Announces the...

Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners

Life Sciences Review | Friday, January 21, 2022
Tweet

San Antonio – RealTime Software Solutions, LLC, a leader in cloud-based software solutions for the clinical research industry, today announced a significant growth investment from LLR Partners. The capital and resources from this partnership will be dedicated to helping accelerate the company’s growth, product innovation and delivery of world-class customer experiences.


RealTime is dedicated to solving problems and providing systems that make the clinical research process more efficient and compliant. The company’s complete Site Operations Management System (SOMS) enables research sites to run better, recruit faster and perform higher through solutions including a Clinical Trial Management System (CTMS), eRegulatory document management (eDOCS), electronic data capture for source documents (eSOURCE), participant payments (SitePAY/GlobalPAY) and participant engagement (TEXT).


“Our vision at RealTime is to reshape the global clinical research industry with innovative solutions that help advance medicine and save lives,” said Rick Greenfield, Founder & CEO of RealTime. “LLR Partners has a long history of investing and supporting the growth of pharma services and technology businesses. As partners, we will be able to access a deep set of resources and experiences to help us deliver enhanced solutions to our customers and enable new pharmaceutical treatments to reach the world at an even faster pace.”


See Also:


Real Estate Business Review 


“The critical work being done by the clinical research industry to improve and save lives has never been more prominent,” said Zack Sigal, Principal at LLR Partners. “RealTime is a leader in the dynamic clinical research technology market with a talented, passionate team dedicated to this purpose. We are excited to partner with Rick Greenfield, Scott Butcher (COO) and their entire team as the company continues to improve the way research sites operate through technology innovation.”


Rick Riegel, a multi-time private equity-backed CEO in pharma technology and services, will join the Board of Directors of RealTime, along with Scott Perricelli and Zack Sigal from LLR Partners. Riegel is a Senior Operating Advisor engaged by LLR and currently serves as Chairman of ActiGraph and Deerfield Agency and previously served as CEO of Phlexglobal and LIQUENT.


Crosstree Capital Partners served as the exclusive financial advisor to RealTime Software Solutions in this transaction.


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing
Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/clinical-research-technology-leader-realtime-secures-growth-investment-from-llr-partners-nwid-699.html